Woman who are X‐ALD carriers (i.e., heterozygous for an ABCD1 pathogenic variant) do not typically develop cerebral disease or adrenal insufficiency (Engelen et al., 2014). This evidence concerns the gene ABCD1 and X-linked adrenoleukodystrophy.